Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CD34-based enrichment of genetically engineered human T cells for clinical use results in dramatically enhanced tumor targeting

5 Jan 2010

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CAR-T cell therapy research
Share to Viral Infectious Diseases and Gene Expression in Insects
Share to Virus-based gene therapy research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 20052466
DOI: 10.1007/s00262-009-0810-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CD34-based enrichment of genetically engineered human T cells for clinical use results in dramatically enhanced tumor targetingPMID 20052466Read ↗

Engineered T cells for anti-cancer therapySemantic proximity Read ↗

Engineered T cells for cancer therapySemantic proximity Read ↗

Current and future concepts for the generation and application of genetically engineered CAR-T and TCR-T cellsSemantic proximity Read ↗

Emerging Cellular Therapies for CancerSemantic proximity Read ↗

Chimeric Antigen Receptor (CAR) T Cells: A Detailed Review of Origins, Engineering, and Therapeutic ImpactSemantic proximity Read ↗

Nanotechnology Promotes Genetic and Functional Modifications of Therapeutic T Cells Against CancerSemantic proximity Read ↗

Genetically engineered T cells for the treatment of cancerSemantic proximity Read ↗

Genetically engineered T cells for cancer immunotherapySemantic proximity Read ↗

Therapeutic T cell engineeringSemantic proximity Read ↗

The Anticancer Potential of T Cell Receptor-Engineered T Cells.Semantic proximity Read ↗

Preferential tumor targeting of HER2 by iPSC-derived CAR T cells engineered to overcome multiple barriers to solid tumor efficacySemantic proximity Read ↗

Fully human CD19-specific chimeric antigen receptors for T-cell therapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.